Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRaw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Total Non-Current Liabilities (2019 - 2022)

Pulmonx (LUNG) has disclosed Total Non-Current Liabilities for 3 consecutive years, with -$172.4 million as the latest value for Q2 2022.

  • On a quarterly basis, Total Non-Current Liabilities changed N/A to -$172.4 million in Q2 2022 year-over-year; TTM through Jun 2022 was -$172.4 million, a N/A change, with the full-year FY2021 number at $41.8 million, changed N/A from a year prior.
  • Total Non-Current Liabilities was -$172.4 million for Q2 2022 at Pulmonx, down from $40.5 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $239.7 million in Q4 2019 to a low of -$172.4 million in Q2 2022.
  • A 3-year average of $37.4 million and a median of $41.1 million in 2021 define the central range for Total Non-Current Liabilities.